These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35873760)

  • 41. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia.
    Clayton JA; Chalothorn D; Faber JE
    Circ Res; 2008 Oct; 103(9):1027-36. PubMed ID: 18802023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Territorial arterial spin labeling in the assessment of collateral circulation: comparison with digital subtraction angiography.
    Chng SM; Petersen ET; Zimine I; Sitoh YY; Lim CC; Golay X
    Stroke; 2008 Dec; 39(12):3248-54. PubMed ID: 18845805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease.
    Kang HS; Kim JH; Phi JH; Kim YY; Kim JE; Wang KC; Cho BK; Kim SK
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):673-8. PubMed ID: 19965844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical features of and risk factors for intracranial aneurysms associated with moyamoya disease.
    Yang H; Zhang L; Wang M; Wang J; Chen L; Lu H
    Int J Stroke; 2021 Jul; 16(5):542-550. PubMed ID: 33176625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging of Moyamoya Disease and Moyamoya Syndrome: Current Status.
    Li J; Jin M; Sun X; Li J; Liu Y; Xi Y; Wang Q; Zhao W; Huang Y
    J Comput Assist Tomogr; 2019; 43(2):257-263. PubMed ID: 30589721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Study of Cerebral Ischemia in Moyamoya Disease from the View of Development of the Anterior Choroidal Artery.
    Ogawa K; Suma T; Akimoto T; Hara M; Fujishiro M; Yoshino A; Nakajima H
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106078. PubMed ID: 34500198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circular RNAs and neutrophils: Key factors in tackling asymptomatic moyamoya disease.
    Corey S; Luo Y
    Brain Circ; 2019; 5(3):150-155. PubMed ID: 31620664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moyamoya Disease.
    Fujimura M; Bang OY; Kim JS
    Front Neurol Neurosci; 2016; 40():204-220. PubMed ID: 27960175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells.
    Hamauchi S; Shichinohe H; Uchino H; Yamaguchi S; Nakayama N; Kazumata K; Osanai T; Abumiya T; Houkin K; Era T
    PLoS One; 2016; 11(9):e0163561. PubMed ID: 27662211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroimaging diagnosis and the collateral circulation in moyamoya disease.
    Liu W; Xu G; Liu X
    Interv Neurol; 2013 Mar; 1(2):77-86. PubMed ID: 25187770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing Ischemic Lesion Patterns and Hemodynamics of the Posterior Cerebral Artery in Moyamoya Disease.
    Wang JZ; He W; Zhang D; Yu LB; Zhao YH; Cai JX
    J Ultrasound Med; 2019 Oct; 38(10):2621-2630. PubMed ID: 30702756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moyamoya disease: a summary.
    Burke GM; Burke AM; Sherma AK; Hurley MC; Batjer HH; Bendok BR
    Neurosurg Focus; 2009 Apr; 26(4):E11. PubMed ID: 19335127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determinants of Basal Collaterals in Moyamoya Disease: Clinical and Genetic Factors.
    Chung JW; Kim SJ; Bang OY; Kim KH; Ki CS; Jeon P; Yeon JY; Kim JS; Hong SC; Shin HJ
    Eur Neurol; 2016; 75(3-4):178-85. PubMed ID: 27046023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease.
    Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhao J
    BMC Neurol; 2020 Jan; 20(1):28. PubMed ID: 31952515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. De Novo Development of Moyamoya Disease in an Adult Female with a Genetic Variant of the RNF-213 Gene: Case Report.
    Tashiro R; Fujimura M; Niizuma K; Endo H; Sakata H; Sato-Maeda M; Tominaga T
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):e8-e11. PubMed ID: 27789153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes to the geometry and fluid mechanics of the carotid siphon in the pediatric Moyamoya disease.
    Jamil M; Tan GX; Huq M; Kang H; Lee ZR; Tang PH; Hu XH; Yap CH
    Comput Methods Biomech Biomed Engin; 2016 Dec; 19(16):1760-1771. PubMed ID: 27166074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features and disease progression in moyamoya disease patients with Graves disease.
    Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
    J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical outcomes following encephaloduroarteriosynangiosis in adult moyamoya disease associated with Type 2 diabetes.
    Ren B; Zhang ZS; Liu WW; Bao XY; Li DS; Han C; Xian P; Zhao F; Wang H; Wang H; Duan L
    J Neurosurg; 2016 Aug; 125(2):308-14. PubMed ID: 26745491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.